Street Highjack By Active Movers: CEL-SCI Corporation (NYSE:CVM), Viavi Solutions (NASDAQ:VIAV)

CEL-SCI Corporation (NYSE:CVM) [Trend Analysis] try to make new thrust in street and making different trends, stocks trading ended with -0.63% to $0.09. CEL-SCI Corporation (NYSEMKT:CVM) announced that NYSE MKT has accepted the Company’s plan to bring itself into compliance with the Exchange’s continued listing standards.

The Company previously received notice from the Exchange on December 9, 2016, indicating the Company is below compliance with Section 1003(a)(i), Section 1003(a)(ii) and Section 1003(a)(iii) since it declared a stockholders’ equity deficit as of June 30, 2016 and had a net losses in its 5 most recent fiscal years ended September 30, 2015.

The Company was afforded the opportunity to submit a plan to regain compliance, and on January 9, 2017 the Company submitted its plan to the Exchange. The share price of CVM attracts active investors, as stock price of week volatility recorded 13.45%. The stock is going forward to its 52-week low with 57.33% and lagging behind from its 52-week high price with -85.70%.

Viavi Solutions Inc. (NASDAQ:VIAV) [Trend Analysis] attempts to attain leading position in street, Shares price changes as it -0.67% to close at $10.37 with the total traded volume of 742232 shares. Viavi Solutions Inc. (VIAV) reported that it plans to offer, subject to market and other conditions, up to $400 million aggregate principal amount of its Senior Convertible Notes due 2024 through a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended.

Viavi expects to grant the initial purchasers a 30-day over-allotment option to purchase up to an additional $60 million aggregate principal amount of additional Notes, exercisable for 30 days after the pricing date of the Notes offering. The interest rate, initial conversion rate and other terms of the Notes will be determined by negotiations between Viavi and the initial purchasers of the Notes.

In certain circumstances and during certain periods, the Notes may be converted at the option of holders into cash up to their principal amount, and into shares of Viavi’s common stock, cash or a combination thereof at Viavi’s election for the conversion value above the principal amount, if any. The firm has institutional ownership of 89.80%, while insider ownership included 0.50%. Its price to sales ratio ended at 2.79. VIAV attains analyst recommendation of 2.50 with week’s performance of -2.43%.


About Gerard Bergeron

Gerard Bergeron covers Bio-pharmacy or healthcare sector Press Releases news updates. He has extensive three year of experience in content writing as freelance writer. He performs analysis of Healthcare Companies and provides worthy information for investor community. He is an experienced writer with a precise grasp of the English language and a clear, compelling writing style.

Leave a Reply

Your email address will not be published. Required fields are marked *